HAIKOU CITY, China, Aug. 3
/PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China
Pharma") (NYSE Amex: CPHI), which develops, manufactures, and
markets specialty pharmaceutical products in China, today announced that it plans to
release its second quarter 2010 financial results before the market
opens on Tuesday, August 10,
2010.
The Company will hold a conference call at 8:00 am ET on August 10,
2010 to discuss second quarter 2010 results. Listeners may
access the call by dialing 1-800-599-9816 or 1-617-847-8705 for
international callers, access code: 52278171. A webcast will also
be available through CPHI's website at
http://www.chinapharmaholdings.com . A replay of the call will be
accessible through August 17, 2010 by
dialing 1-888-286-8010 or 1-617-801-6888 for international callers,
access code: 49499602.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical
company with rapidly growing profit that develops, manufactures,
and markets treatments for a wide range of high incidence and high
mortality conditions in China,
including cardiovascular, CNS, infectious, and digestive diseases.
The Company's cost-effective, high margin business model is driven
by market demand and supported by eight scalable GMP-certified
product lines covering the major dosage forms. In addition, the
Company has a broad and expanding distribution network across 30
provinces, municipalities and autonomous regions. The Company is
registered in Delaware, USA.
Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson),
located in Haikou City,
Hainan Province, China, is a wholly owned subsidiary of China
Pharma Holdings, Inc. For more information about China Pharma
Holdings, Inc., please visit http://www.chinapharmaholdings.com
.
For more information, please contact:
China Pharma Holdings, Inc.
Phone: +86-898-6681-1730 (China)
Email: hps@chinapharmaholdings.com
CCG Investor Relations
Kalle Ahl, Account Manager
Phone: +1-646-833-3417(New York)
Email: kalle.ahl@ccgir.com
Vivian Chen, Sr. Market Intelligence Exec.
Phone: +1-646-701-7445(New York)
Email: vivian.chen@ccgir.com
SOURCE China Pharma Holdings, Inc.
Copyright g. 3 PR Newswire